Completed Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer NCT02267603 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more Locations Stanford Cancer Institute Palo Alto — Palo Alto, California, United States UCSF Medical Center-Mount Zion — San Francisco, California, United States Yale University — New Haven, Connecticut, United States Moffitt Cancer Center — Tampa, Florida, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma NCT01204476 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 Conditions Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
